Hepatitis C virus and lymphoma

Journal of Clinical Pathology

Volumn 60, Issue 12, 2007, Pages 1378-1383

  Viswanatha, D S ^a   Dogan, A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN;

ANTIVIRAL THERAPY; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTOMA; LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; HEPATITIS C; HUMANS; INTERFERONS; LYMPHOMA, NON-HODGKIN;

EID: 37049006722     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.051870     Document Type: Review

References (47)

1. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
2. Takada N, Takase S, Takada A, et al. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993;17:277-83.
3. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-8.
4. Mahaney K, Tedeschi V, Maertens G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994;20:1405-11.
5. Sterling RK, Bralow SP. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 2006;8:53-9.
6. Zignego AL, Ferri C, Pileri SA, et al. Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 2007;39:2-17.
7. Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis 2005;37:219- 26.
8. Libra M, Gasparotto D, Gloghini A, et al. Hepatitis C virus (HCV) infection and lymphoproliferative disorders. Front Biosci 2005;10:2460-71.
9. Franzin F, Efremov DG, Pozzato G, et al. Clonal B-cell expansions in peripheral blood of HCV-infections patients. Br J Haematol 1995;90:548-52.
10. Sansonno D, De Vita S, Iacobelli AR, et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160:3594-601.
11. Magalini AR, Facchetti F, Salvi L, et al. Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers. J Pathol 1998;185:86-90.
12. Racanelli V, Sansonno D, Piccoli C, et al. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001;167:21-9.
13. Rasul I, Shepherd FA, Kamel-Reid S, et al. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999;29:543-7.
14. Saadoun D, Landau DA, Calabrese LH, et al. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology 2007;46:1234-42.
15. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-74.
16. Mazzaro C, Franzin F, Tulissi P, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996;77:2604-13.
17. Mazzaro C, Pazzato G, Moretti M, et al. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia. Haematologica 1994;79:342-9.
18. Misiani R, Bellavita P, Fenili D, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
19. Casato M, Mecucci C, Agnello V, et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002;99:2259-61.
20. Negri E, Little D, Boiocchi M, et al. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004;111:1-8.
21. Morgensztern D, Rosado MF, Silva O, et al. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in south Florida and review of the literature. Leuk Lymphoma 2004;45:2459-64.
22. McOmber Morten L, Engels EA, Holford TR, et al. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev 2004;13:425-30.
23. Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004;111:76-80.
24. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007;297:2010-7.
25. Nieters A, Kallinowski B, Brennan P, et al. Hepatitis C and risk of lymphoma: results of the European Multicenter Case-Control Study EPILYMPH. Gastroenterology 2006;131:1879-86.
26. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006;15:2078-85.
27. Matsuo K, Kusano A, Sugumar A, et al. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004;95:745-52.
28. Besson C, Canioni D, Lepage E, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol 2006;24:953-60.
29. Weng W-K, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 2003;44:1113-20.
30. Sansonno D, Tucci FA, Lauletta G, et al. Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia. Clin Exp Immunol 2006;147:241-48.
31. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992;256:105-7.
32. Petracca R, Falugi F, Galli G, et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 2000;74:4824-30.
33. Rosa D, Saletti G, De Gregorio E, et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005;102:18544-9.
34. L kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998;91:2433-42.
35. De Re V, De Vita S, Marzotto A, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000;96:3578-84.
36. Machida K, Cheng K T-N, Sung V M-H, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 2004;101:4262-7.
37. Machida K, Cheng K T-H, Pavio N, et al. Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 2005;79:8079-89.
38. Hofmann WP, Fernandez B, Herrmann E, et al. Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases. J Viral Hepat 2007;14:484-91.
39. Libra M, Capello D, Gloghini A, et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol 2005;206:87-91.
40. Zignego AL, Ferri C, Giannelli F, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002;137:571-80.
41. Kitay-Cohen Y, Amiel A, Hilzenrat N, et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000;96:2910-2.
42. Zuckerman E, Zuckerman T, Sahar D, et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001;112:364-9.
43. Sasso EH, Martinez M, Yarfitz SL, et al. Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18). J Immunol 2004;173:3549-56.
44. Libra M, De Re V, De Vita S, et al. Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue. Leukemia 2003;17:1433-6.
45. Libra M, De Re V, Gloghini A, et al. Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. Haematologica 2004;89:873-4.
46. Saadoun D, Suarez F, Lefrere F, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005;105:74-6.
47. Hermine O, Lefrere F, Bronowicki J-P, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94.